Abstract

Lichens have been widely used in traditional medicine, especially by indigenous communities worldwide. However, their slow growth and difficulties in the isolation of lichen symbionts and associated microbes have hindered the pharmaceutical utilisation of lichen-produced compounds. Advances in high-throughput sequencing techniques now permit detailed investigations of the complex microbial communities formed by fungi, green algae, cyanobacteria, and other bacteria within the lichen thalli. Here, we used amplicon sequencing, shotgun metagenomics, and in silico metabolomics together with compound extractions to study reindeer lichens collected from Southern Finland. Our aim was to evaluate the potential of Cladonia species as sources of novel natural products. We compared the predicted biosynthetic pathways of lichen compounds from isolated genome-sequenced lichen fungi and our environmental samples. Potential biosynthetic genes could then be further used to produce secondary metabolites in more tractable hosts. Furthermore, we detected multiple compounds by metabolite analyses, which revealed connections between the identified biosynthetic gene clusters and their products. Taken together, our results contribute to metagenomic data studies from complex lichen-symbiotic communities and provide valuable new information for use in further biochemical and pharmacological studies.

Highlights

  • Lichens are complex microbial assemblages recently redefined as ‘self-sustaining ecosystems’ [1], involving filamentous fungal, green algal or cyanobacterial, and additional prokaryotic and yeast-like fungal partners living in symbiosis [2]

  • The main aim when evaluating the microbial communities within the studied lichens was to observe which microorganisms could be present in these samples that would be further explored for their biotechnological potential

  • internal transcribed spacer 2 (ITS2) operational taxonomic units (OTUs) sequencing of the eukaryote community confirmed that the main mycobiont partner in all six specimens is represented by species of the lichenised fungal genus Cladonia, namely Cladonia arbuscula, Cladonia mitis, Cladonia rangiferina, Cladonia stellaris, and Cladonia uncialis

Read more

Summary

Introduction

Lichens are complex microbial assemblages recently redefined as ‘self-sustaining ecosystems’ [1], involving filamentous fungal, green algal or cyanobacterial (or both), and additional prokaryotic and yeast-like fungal partners living in symbiosis [2]. Lichens are common worldwide in almost all terrestrial environments and exist in diverse morphological forms [3,4]. Animals such as reindeer graze on lichens during the winter [5] and some lichens have even been used as emergency food by humans in the past [6]. Interest in the pharmacological use of lichens has increased with the greater awareness of the environmental problems related to synthetic medicines and emerging Natural products produced within lichen thalli are known to include compounds with antifungal, antibacterial, anti-inflammatory, antioxidant, and antiproliferative activities [8,9,10,11].

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call